Pricing Log in Create free account

Compass Therapeutics, Inc. (CMPX) vs Spruce Biosciences, Inc. (SPRB)

Compass Therapeutics, Inc. and Spruce Biosciences, Inc. are both Biotechnology companies. Compass Therapeutics, Inc. and Spruce Biosciences, Inc. are of similar size ($136.7M and $133.8M). Across the 10 metrics below, Compass Therapeutics, Inc. leads on 6 and Spruce Biosciences, Inc. on 4.

Valuation

Metric CMPX SPRB Biotechnology median
P/E n/m n/m 10.60
P/S n/m 23.04 9.40
P/B 0.86 1.35 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.40 n/m 0.66
EV/Sales n/m 4.88 9.02
Earnings yield (52.63%) (88.60%) (32.88%)
Free cash flow yield (39.71%) (37.80%) (23.13%)

Profitability

Metric CMPX SPRB Biotechnology median
Gross margin 0.00% 100.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (56.66%) (105.98%) (51.96%)
Return on assets (47.87%) (82.38%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CMPX SPRB Biotechnology median
Revenue growth (TTM) — (51.32%) 6.76%
EPS growth (last fiscal year) (16.67%) 47.59% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CMPX SPRB Biotechnology median
Debt to equity 0.00 0.08 0.00
Current ratio 11.22 9.23 4.97
Net debt to EBITDA 2.86 1.34 1.01

Dividend

Metric CMPX SPRB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CMPX SPRB Biotechnology median
Market cap 136.65m 133.79m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack